Keywords: Hi-Tech, Mylan, Keppra, Lexapro, UCB, Forest Labs, USA, FDA

Hi-Tech and Mylan update on generics

Article | 01 March 2012

US generic drugmaker Hi-Tech Pharmacal (Nasdaq: HITK) says that the US Food and Drug Administration has granted final approval for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in